CRIS Current Research Information System

BIASCO, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.873
AS - Asia 14.678
EU - Europa 12.165
AF - Africa 980
SA - Sud America 876
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 12
Totale 47.617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.660
VN - Vietnam 4.306
SG - Singapore 3.958
CN - Cina 3.744
GB - Regno Unito 3.457
DE - Germania 1.480
IT - Italia 1.468
SE - Svezia 1.328
HK - Hong Kong 854
FR - Francia 841
IN - India 745
RU - Federazione Russa 728
BR - Brasile 626
IE - Irlanda 553
UA - Ucraina 533
CH - Svizzera 526
ZA - Sudafrica 335
NL - Olanda 288
JP - Giappone 254
EE - Estonia 248
TG - Togo 225
FI - Finlandia 203
CI - Costa d'Avorio 154
CA - Canada 132
JO - Giordania 105
SC - Seychelles 98
BG - Bulgaria 97
PH - Filippine 94
AR - Argentina 90
AT - Austria 87
KR - Corea 86
NG - Nigeria 86
TH - Thailandia 76
BE - Belgio 74
PL - Polonia 62
ID - Indonesia 61
BD - Bangladesh 57
IQ - Iraq 50
MX - Messico 48
EC - Ecuador 46
GR - Grecia 43
IR - Iran 42
CL - Cile 39
TR - Turchia 39
TW - Taiwan 35
PK - Pakistan 33
AU - Australia 28
ES - Italia 24
CO - Colombia 23
LT - Lituania 22
MY - Malesia 22
RO - Romania 22
HR - Croazia 19
PY - Paraguay 19
LB - Libano 18
SA - Arabia Saudita 17
EG - Egitto 16
UZ - Uzbekistan 15
VE - Venezuela 13
PE - Perù 12
MA - Marocco 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
JM - Giamaica 9
SK - Slovacchia (Repubblica Slovacca) 9
ET - Etiopia 8
KE - Kenya 8
KZ - Kazakistan 8
NP - Nepal 8
A2 - ???statistics.table.value.countryCode.A2??? 7
PS - Palestinian Territory 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AO - Angola 6
CR - Costa Rica 6
DZ - Algeria 6
IL - Israele 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
HU - Ungheria 4
MU - Mauritius 4
SV - El Salvador 4
BH - Bahrain 3
DK - Danimarca 3
GH - Ghana 3
MK - Macedonia 3
OM - Oman 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
EU - Europa 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 47.574
Salva come PNG Salva come JPEG
Città #
Southend 3.142
Singapore 2.660
Fairfield 1.888
Ashburn 1.844
Chandler 1.488
Woodbridge 937
Wilmington 930
Houston 880
San Jose 877
Dong Ket 821
Hong Kong 810
Ho Chi Minh City 803
Seattle 789
Santa Clara 784
Hanoi 728
Princeton 690
Cambridge 627
Ann Arbor 585
Beijing 517
Bern 499
Dublin 499
Boardman 383
Lauterbourg 321
Jacksonville 304
Nanjing 303
Westminster 296
Bologna 284
Padova 282
New York 266
Lomé 225
Los Angeles 218
Tokyo 218
Dallas 204
Helsinki 187
Berlin 178
Jinan 175
Hefei 158
Abidjan 154
Shenyang 146
Saint Petersburg 140
San Diego 121
Medford 120
Buffalo 116
Menlo Park 112
Haiphong 110
Changsha 108
Frankfurt am Main 106
Nanchang 104
Amman 101
Redondo Beach 99
Sofia 97
Da Nang 93
Guangzhou 93
Milan 92
Hebei 91
Turin 88
Mülheim 86
Jiaxing 84
Tianjin 83
São Paulo 77
Shanghai 76
Abeokuta 73
Brussels 65
Hangzhou 63
Florence 62
Council Bluffs 61
Dearborn 60
Falls Church 59
Zhengzhou 59
Des Moines 54
Redmond 54
Toronto 54
Vienna 53
Orem 52
Chicago 49
Kuban 49
Warsaw 49
Yubileyny 49
Norwalk 48
Taiyuan 46
Bremen 45
Johannesburg 43
Phoenix 41
Seoul 41
Taizhou 40
The Dalles 40
Rome 39
Munich 38
Hải Dương 37
Ningbo 37
Fremont 36
Haikou 35
Olalla 35
Redwood City 35
London 34
Biên Hòa 33
Bühl 33
Mahé 33
San Francisco 33
Wuhan 33
Totale 31.097
Salva come PNG Salva come JPEG
Nome #
The National Tumor Association Foundation (ANT): A 30 year old model of home palliative care. 516
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 396
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 390
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer 307
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 277
The 'surprise' question in advanced cancer patients: A prospective study among general practitioners. 275
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 268
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 261
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 261
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 259
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 259
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 254
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 253
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 250
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 248
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 246
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 246
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 245
Cardiac metastasis of melanoma. 244
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 242
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 236
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 235
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 229
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 227
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 226
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 225
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 223
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 221
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 220
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 219
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 218
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 215
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 215
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 210
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 210
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 210
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 210
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 210
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 210
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 209
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 208
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 205
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 205
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 205
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 204
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 204
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 204
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 203
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. 203
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 203
Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading 203
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 203
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 202
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 201
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 200
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 200
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 199
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 197
High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. 196
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 195
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 195
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 193
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 191
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 190
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 189
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 189
In Reply 189
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 188
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 187
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 186
La comunicazione con il paziente al termine della vita 185
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 183
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 183
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 183
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 183
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 182
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 182
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 181
An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol 181
Treatment of colorectal cancer liver metastases 180
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 179
Second-line chemotherapy in patients with biliary tract cancer. 178
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 177
Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review. 177
State of the art biological therapies in pancreatic cancer 177
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 176
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 176
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies 175
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 174
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 174
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 172
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 171
Cell proliferation and differentiation in familial adenomatous polyposis (FAP). 170
Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries 170
Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience 169
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 169
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 169
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 169
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 168
Totale 21.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.919 0 0 0 0 0 0 0 0 0 192 191 1.536
2021/20226.010 614 258 322 437 527 299 152 349 279 424 1.272 1.077
2022/20236.568 740 950 334 814 384 418 144 387 1.026 192 524 655
2023/20241.667 165 276 71 190 132 419 77 110 45 87 51 44
2024/20255.776 207 967 476 432 1.218 289 414 169 48 416 123 1.017
2025/202612.920 1.193 934 1.211 936 1.600 824 1.403 556 3.201 1.062 0 0
Totale 48.492